Home  >  Companies  >  SandboxAQ
SandboxAQ
Software suite using AI and quantum tech for drug discovery, cybersecurity, and navigation

Funding

$1.30B

2022

Details
Headquarters
Palo Alto, CA
Website
Milestones
FOUNDING YEAR
2022
Overview

Funding Rounds

Share Name Issue Price Issued At
Series E $17.21 Apr 2025
Share Name Issue Price Issued At
Series D $9.43 Mar 2022
View the source Certificate of Incorporation copy.

News

June 18, 2025

SandboxAQ Launches Groundbreaking Dataset to Transform Drug Discovery

SandboxAQ's innovative dataset enhances drug discovery efficiency, potentially accelerating the development of new therapies and reshaping the pharmaceutical landscape by reducing costs and time-to-market for critical medications.
June 16, 2025

SandboxAQ to Showcase Quantum and AI Innovations at Nexus Luxembourg

SandboxAQ's showcase of quantum and AI innovations at Nexus Luxembourg highlights the growing intersection of advanced technologies, potentially reshaping industries and enhancing competitive advantages in a rapidly evolving digital landscape.
April 24, 2025

SandboxAQ Launches AQtive Guard to Secure Non-Human Identities Amid AI Surge

SandboxAQ's launch of AQtive Guard addresses the critical need for securing non-human identities, positioning the company at the forefront of AI security solutions amid growing concerns over digital identity threats.

DISCLAIMERS

This report is for information purposes only and is not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise constitutes a personal trade recommendation to you.

This research report has been prepared solely by Sacra and should not be considered a product of any person or entity that makes such report available, if any.

Information and opinions presented in the sections of the report were obtained or derived from sources Sacra believes are reliable, but Sacra makes no representation as to their accuracy or completeness. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a determination at its original date of publication by Sacra and are subject to change without notice.

Sacra accepts no liability for loss arising from the use of the material presented in this report, except that this exclusion of liability does not apply to the extent that liability arises under specific statutes or regulations applicable to Sacra. Sacra may have issued, and may in the future issue, other reports that are inconsistent with, and reach different conclusions from, the information presented in this report. Those reports reflect different assumptions, views and analytical methods of the analysts who prepared them and Sacra is under no obligation to ensure that such other reports are brought to the attention of any recipient of this report.

All rights reserved. All material presented in this report, unless specifically indicated otherwise is under copyright to Sacra. Sacra reserves any and all intellectual property rights in the report. All trademarks, service marks and logos used in this report are trademarks or service marks or registered trademarks or service marks of Sacra. Any modification, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, or selling any report is strictly prohibited. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Sacra. Any unauthorized duplication, redistribution or disclosure of this report will result in prosecution.